Title:A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
VOLUME: 1 ISSUE: 1
Author(s):Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
Affiliation:Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Rd., La Jolla, CA 92037, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Rd., La Jolla, CA 92037, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Rd., La Jolla, CA 92037
Keywords:Covid-19, BCG vaccination, Sars-CoV-2 B-cell epitopes, bioinformatics analysis, tuberculosis vaccine, Mycobacterium
bovis.
Abstract:
Objective: Our goal was to elucidate a potential molecular link between the past and current
tuberculosis vaccine Bacillus Calmette-Guérin (BCG; a live attenuated strain of Mycobacterium bovis)
immunization policies and COVID-19.
Methods: Our sequence homology analyses have demonstrated that there is an intriguing level of sequence
homology between a few of the BCG and Sars-CoV-2 proteins.
Results: The data suggest that the BCG-specific memory B-cells that are preserved in BCG-vaccinated
patients cross-recognize SARS-CoV-2 and that this cross-recognition may affect the virus proliferation
and COVID-19 severity.
Conclusion: Our results can stimulate the sharply focused follow-up experimental studies.